Literature DB >> 30599219

Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review.

Peter Dome1, Laszlo Tombor2, Judit Lazary3, Xenia Gonda4, Zoltan Rihmer5.   

Abstract

Given the moderate efficacy of the currently available antidepressants (ADs) in the treatment of major depressive disorder (MDD), the identification of agents that are both able to enhance the effectiveness of ADs and have a good safety profile is a reasonable task for current psychopharmacology. In addition to the well-known drugs (second-generation antipsychotics, levothyroxine, dopaminergic agents, etc.) for augmentation, investigations suggest that several nutraceuticals and over-the-counter (OTC) drugs may be effective and safe as adjunct therapeutic agents to conventional ADs. To identify such active ingredients we first performed a systematic literature search using PubMed and then conducted both backward and forward citation searches. For the PubMed search, we used the following combinations of keywords: 1) "adjunctive" + "therapy" + "antidepressant"; 2) "add-on" + "therapy" + "antidepressant"; 3) "supplementation" + "therapy" + "antidepressant". As a result of those efforts, we found more than 20 agents (e.g. S-Adenosyl-L-Methionine; folate; ω-3 fatty acids; curcumin; N-acetylcysteine; saffron; 5-hydroxytryptophan; NSAIDs) that are supposedly effective in the augmentation of standard AD treatment. We discussed the possible mechanisms of the antidepressant actions of those agents, as well as the preclinical and clinical evidence for their efficacy as stand-alone and adjunct treatments for MDD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Add-on; Adjunctive; Antidepressant; Major depressive disorder; Micronutrients; Nutraceutical

Mesh:

Substances:

Year:  2018        PMID: 30599219     DOI: 10.1016/j.brainresbull.2018.12.015

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  8 in total

Review 1.  Current Research on Complementary and Alternative Medicine (CAM) in the Treatment of Major Depressive Disorder: An Evidence-Based Review.

Authors:  Vladimir Trkulja; Hrvoje Barić
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  LPS-induced impairment of Na+/K+-ATPase activity: ameliorative effect of tannic acid in mice.

Authors:  Karina Pereira Luduvico; Luiza Spohr; Mayara Sandrielly Soares de Aguiar; Fernanda Cardoso Teixeira; Natália Pontes Bona; Julia Eisenhardt de Mello; Roselia Maria Spanevello; Francieli Moro Stefanello
Journal:  Metab Brain Dis       Date:  2022-06-27       Impact factor: 3.655

3.  Antidepressant-like effect of Campomanesia xanthocarpa seeds in mice: Involvement of the monoaminergic system.

Authors:  Gabriela Sabrina Anzollin; Lilian Zaki; Thalita Maria Perin; Bruna Finger; Letícia Trentin Perin; Fernanda Petry; Thalia Sebulsqui Saraiva; Maria Luiza Lima da Costa Lopes; Andresa Heemann Betti; Jaqueline Scapinello; J Vladimir Oliveira; Jacir Dal Magro; Liz G Müller
Journal:  J Tradit Complement Med       Date:  2021-08-30

4.  Antidepressant-like Activity of Patchouli Oil var. Tapak Tuan (Pogostemon cablin Benth) via Elevated Dopamine Level: A Study Using Rat Model.

Authors:  Puji Astuti; Khairan Khairan; Marthoenis Marthoenis; Kartini Hasballah
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-15

5.  Multidimensional Liquid Chromatography Employing a Graphene Oxide Capillary Column as the First Dimension: Determination of Antidepressant and Antiepileptic Drugs in Urine.

Authors:  Edvaldo Vasconcelos Soares Maciel; Ana Lúcia de Toffoli; Jussara da Silva Alves; Fernando Mauro Lanças
Journal:  Molecules       Date:  2020-02-29       Impact factor: 4.411

6.  Anti-Inflammatory Effects of Asian Fawn Lily (Erythronium japonicum) Extract on Lipopolysaccharide-Induced Depressive-Like Behavior in Mice.

Authors:  Dong Wook Lim; Joon Park; Daeseok Han; Jaekwang Lee; Yun Tai Kim; Changho Lee
Journal:  Nutrients       Date:  2020-12-11       Impact factor: 5.717

7.  Antianhedonic and Antidepressant Effects of Affron®, a Standardized Saffron (Crocus Sativus L.) Extract.

Authors:  Laura Orio; Francisco Alen; Antonio Ballesta; Raquel Martin; Raquel Gomez de Heras
Journal:  Molecules       Date:  2020-07-15       Impact factor: 4.411

8.  In vitro model of perimenopausal depression implicates steroid metabolic and proinflammatory genes.

Authors:  Sarah Rudzinskas; Jessica F Hoffman; Pedro Martinez; David R Rubinow; Peter J Schmidt; David Goldman
Journal:  Mol Psychiatry       Date:  2020-08-12       Impact factor: 13.437

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.